Success Metrics

Clinical Success Rate

100.0%

Based on 4 completed trials

Completion Rate

100%(4/4)

Active Trials

0(0%)

Results Posted

0%(0 trials)

Phase Distribution

Ph phase_1

33%

Ph not_applicable

67%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution6 total trials

Phase 1Safety & dosage

2(33.3%)

N/ANon-phased studies

4(66.7%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

80.0%

4 of 5 finished

Non-Completion Rate

20.0%

1 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(1)

Completed(4)

Terminated(1)

Detailed Status

Completed4

Not yet recruiting1

Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 1

Trials by Phase

Phase 12 (33.3%)

N/A4 (66.7%)

Trials by Status

not_yet_recruiting117%

completed467%

withdrawn117%

Recent Activity

0 active trials

Showing 5 of 6

completednot_applicable

Effect of Caffeinated Chewing Gum on Vertical Jump Performance in Female Volleyball Players

NCT07240506

completednot_applicable

Clinical Trials (6)

Showing 6 of 6 trials

NCT07240506Not Applicable

Effect of Caffeinated Chewing Gum on Vertical Jump Performance in Female Volleyball Players

Completed

NCT06029283Not Applicable

Dietary Nitrate Functional Gum Effect on Gingivitis and Heart Health

Completed

NCT07054645Not Applicable

Elderberry Functional Gum and Cognitive & Oral Health in Older Adults

Not Yet Recruiting

NCT05433181Phase 1

ACE2 Chewing Gum on SARS-CoV-2 Viral Load (COVID 19)

Withdrawn

NCT04284696Not Applicable

Chewing Gum Containing Vitamin-c to Treat Emesis Gravidarum

Completed

NCT01057108Phase 1

Double Blind Randomized Placebo Controlled Trial of FOSTRAP Chewing Gum in Patients With CKD and Hyperphosphatemia

Completed

All 6 trials loaded

Drug Details

Intervention Type: DIETARY SUPPLEMENT
Total Trials: 6